Lipocine Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Lipocine Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Lipocine Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $47.8M, a 4.14% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $47.8M +$1.9M +4.14% Dec 31, 2023 10-K 2024-03-07
Q4 2022 $45.9M +$2.84M +6.61% Dec 31, 2022 10-K 2024-03-07
Q4 2021 $43M +$563K +1.33% Dec 31, 2021 10-K 2023-03-10
Q4 2020 $42.5M +$5.19M +13.9% Dec 31, 2020 10-K 2022-03-09
Q4 2019 $37.3M +$3.77M +11.3% Dec 31, 2019 10-K 2021-03-11
Q4 2018 $33.5M +$2.68M +8.7% Dec 31, 2018 10-K 2020-03-13
Q4 2017 $30.8M -$5.09M -14.2% Dec 31, 2017 10-K 2019-03-06
Q4 2016 $35.9M +$7.7M +27.3% Dec 31, 2016 10-K 2018-03-12
Q4 2015 $28.2M +$7.31M +35% Dec 31, 2015 10-K 2017-03-06
Q4 2014 $20.9M +$9.23M +79.1% Dec 31, 2014 10-K 2016-03-10
Q4 2013 $11.7M +$40.7K +0.35% Dec 31, 2013 10-K 2015-03-11
Q2 2013 $13.2K* Jun 30, 2013 10-Q 2013-07-09
Q1 2013 -$12.8K* Mar 31, 2013 10-Q 2013-04-24
Q4 2012 $11.6M +$11.6M Dec 31, 2012 10-K 2014-03-31
Q4 2011 -$774* Dec 31, 2011 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.